940TiP INTerpath-007: A phase II/III, adaptive, randomized study of neoadjuvant and adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) for treatment of resectable locally advanced (LA) cutaneous squamous cell carcinoma (cSCC)
| Autor: | Ladwa, R., Davar, D., Lee, J., Silk, A.W., Popovtzer, A., Asher, N., Khattak, M.A., Meehan, R., Posadas, T., Wang, A., Yuan, J., Gross, N., Koyfman, S., Schadendorf, D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S652-S653 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|